Letter

COPD

Drug management of COPD

BMJ 2007; 334 doi: 10.1136/bmj.39191.719352.3A (Published 26 April 2007)
Cite this as: BMJ 2007;334:864.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter D Burrill, specialist pharmaceutical adviser for public health
  1. Derbyshire County Primary Care Trust, Chesterfield S41 7PF
  1. peter.burrill{at}derbyshirecountypct.nhs.uk

    In the second step of prescribing for long term management of chronic obstructive pulmonary disease, McIvor and Little recommend the addition of a long acting β2 agonist (LABA) to a short acting β2 agonist as needed, supplemented by stepwise addition of regular short or long acting anticholinergic inhalers.1 I agree …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular